Monitoring Eating Across Locations (MEAL) - Timing, Intake, and Mealtime Evaluation (TIME)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6-9
SponsorPenn State University

About this trial

Increased availability of high-energy dense foods has contributed to a pediatric obesity epidemic, with 23% of United States children currently presenting with the disease. How children eat contributes to both overconsumption and greater adiposity. However, it is unclear if laboratory measures of children's eating style generalize to the home environment, where children consume two thirds of their total energy. The study will 1) test if child eating styles observed in the lab generalize to more ecologically valid home environments and 2) identify aspects of home food environment that amplify obesogenic eating behaviors. We will assess laboratory and home eating styles (e.g., bite rate) in 100 prepubertal 6-9-year-old children to constrain variability in energy requirements. Children will be video-recorded while consuming identical study-provided meals at home and in the laboratory (counter-balanced order) in addition to a 'typical' meal at home. To study how adiposity relates to "obesogenic" styles of eating, gold standard dual x-ray absorptiometry will be used.

Eligibility criteria

Qualifiers

children must be between the ages of 6-9 years-old

children are of good health with no learning disabilities (e.g., ADHD, determined by parent report)

children are not on any medications known to impact body weight, taste, food intake, behavior, or blood flow

parents report that children like and are willing to eat study foods

Disqualifiers

Children are not within the age requirements (<6 years old or > 9 years old)

If children are taking cold or allergy medication, or other medications known to influence cognitive function, taste, appetite, or blood flow.

If children don't speak English.

If children are colorblind.

Trial design

Treatments tested in this trial

  • Meal Location

Treatment groups

100 Participants
are divided into 1 treatment group

Sponsors and collaborators